The engineering maturity of Verxalus is the result of a rigorous development process. As demonstrated in the accompanying video of our early working prototype, the project initially envisioned a high-end, robotic targeting system. This version integrated micro-cameras, LED lighting, and AI-driven computer vision to identify fecal matter and automatically pilot the micro-actuators, directing the tangential jet with surgical precision.
While this phase successfully validated the technical feasibility of our two-axis kinematics, it also prompted a strategic pivot based on global market demands. We realized that the true disruptive value of our innovation lies in the intrinsic cleanliness of the horizontal jet. By stripping away the complex software loops and motorized nozzles required by competitors, we adapted our robust mechanism to a manual, analog control system.
This versatility is our greatest commercial asset. It allows us to approach the mass-market B2C sector with ultra-reliable, mechanical versions, while simultaneously offering high-budget B2B healthcare markets the automated, sensor-rich diagnostic hubs.
We are offering a protected, multi-tiered technological ecosystem. We welcome inquiries from industrial partners, investors, and digital health pioneers interested in licensing or joint development opportunities to scale a product that disrupts both traditional sanitaryware and preventative healthcare.






